글로벌 Organ-On-Chip 시장 – 2029년까지의 산업 동향 및 예측

시장 분석 및 규모

연구자들은 수년에 걸쳐 랩온칩(LOC)과 세포 생물학을 결합하여 장기 특정 환경에서 인간 생리학을 조사해 왔습니다. 그 결과 시험관 내 다세포 인간 유기체의 새로운 모델이 등장했습니다.

칩상 장기 시장은 2021년에 5,705만 달러로 평가되었으며, 2029년까지 1억 4,431만 달러에 도달할 것으로 예상되며, 2022-2029년 예측 기간 동안 12.30%의 CAGR을 기록할 것입니다. Data Bridge Market Research 팀이 큐레이팅한 시장 보고서에는 시장 가치, 성장률, 시장 세그먼트, 지리적 범위, 시장 참여자, 시장 시나리오와 같은 시장 통찰력 외에도 심층적인 전문가 분석, 수입/수출 분석, 가격 분석, 생산 소비 분석, 페슬 분석이 포함되어 있습니다.

시장 정의

칩상 장기 시장은 약물 개발, 독성 시험 및 개인화된 의학 연구를 위해 칩상 장기를 제조하는 기관(조직, 단독 거래자 및 파트너십)이 칩상 장기를 판매하는 것으로 구성됩니다. 칩상 장기(OOC)는 생체적합성 미세유체 챔버가 있는 소형 플라스틱 장치로, 신체 기관의 중요한 생리적 과정을 모방하는 수많은 살아있는 인간 세포의 3D 배양을 담고 있습니다.

보고 범위 및 시장 세분화

Organ-On-Chip 시장 동향

This section deals with understanding the market drivers, opportunities, restraints and challenges. All of this is discussed in detail as below:

Drivers

• Increase in Research Activities

The organ-on-chip industry is encouraged by determinants, such as a demand for substitutes for animal experimentation, the requirement for the initial discovery of remedy toxicity, and unique product launch and elevations in technology are also accountable for stimulating the market.

• Initiatives by Pharmaceutical Companies

The growing efforts by pharmaceutical corporations to finance and examine medication repurposing using organ-on-chip patterns, are also foreseen to push the increment of the organ-on-chip business.

• Integration of Technologies

The increase in demand for organ-on-chip as it combines tissue engineering and microfluidics. These technologies offer effective answers to long standing issues in individualized disease treatment and medication discovery. The technology assist in drug development studies.

Additionally, rapid urbanization, lifestyle change, investments, and increased consumer spending positively impact the organ-on-chip market.

Opportunities

Furthermore, an increase in need for personalized medicine extend profitable opportunities to the market players in the forecast period of 2022 to 2029. Also, widespread employment of organ-on-chip surpassing the medical enterprise will further expand the market.

Restraints/Challenges

On the other hand, high cost associated with the organ chip device and the development of organ-on-chip (OOC) technology are expected to obstruct market growth. Also, stringent regulations are projected to challenge the organ-on-chip market in the forecast period of 2022-2029.

This organ-on-chip market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on organ-on-chip market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Covid-19 Impact on Organ-On-Chip Market

The COVID-19 had a negative impact on the organ-on-chip market owing to the strict lockdowns and social distancing to contain the spread of the virus. The economic uncertainty, partial shutdown of the business and low consumer confidence impacted demand organ-on-chip technology. The supply chain got hampered during the pandemic along with delay logistics activities. However, the organ-on-chip market is expected to regain its pace during the post-pandemic scenario due to the easing on the restrictions.

Global Organ-On-Chip Market Scope and Market Size

The organ-on-chip market is segmented on the basis of organ type, application, and end user. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Organ Type

• Liver
• Heart
• Lung
• Other Organ Types

Application

• Drug Discovery
• Toxicology Research
• Others

End User

• Pharmaceutical and Biotechnology Companies
• Academic and Research Institutes
• Other

Organ-On-Chip Market Regional Analysis/Insights

The organ-on-chip market is analysed and market size insights and trends are provided by country, organ type, application, and end user as referred above.

The countries covered in the organ-on-chip market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, Israel, Egypt, South Africa, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the organ-on-chip market because of the availability of an extensive array of assistance extended by significant market pros and an increment in the toxicological analysis of drugs on the distinct varieties of organ cells.

Asia-Pacific (APAC) is expected to witness significant growth during the forecast period of 2022 to 2029 because of the adoption of advanced technology in the region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

경쟁 환경 및 칩상 장기 시장

organ-on-chip 시장 경쟁 구도는 경쟁자별 세부 정보를 제공합니다. 포함된 세부 정보에는 회사 개요, 회사 재무, 창출된 수익, 시장 잠재력, 연구 개발 투자, 새로운 시장 이니셔티브, 글로벌 입지, 생산 현장 및 시설, 생산 용량, 회사의 강점과 약점, 제품 출시, 제품 폭과 범위, 응용 분야 우위가 있습니다. 위에 제공된 데이터 포인트는 organ-on-chip 시장과 관련된 회사의 초점에만 관련이 있습니다.

칩상 장기 시장에서 운영되는 주요 업체 중 일부는 다음과 같습니다.

• AxoSim (미국)
• BiomimX Srl(이탈리아)
• 엘브플로우(프랑스)
• 에뮬레이트 주식회사(미국)
• Hµrel Corporation (미국)
• InSphero(스위스)
• MIMETAS(네덜란드)
• NORTIS, INC. (미국)
• TARA Biosystems, Inc. (미국)
• 로고 TissUse GmbH (독일)

SKU-53532